Skip to main content

Thermo Fisher Scientific Axiom Microbiome Array

Thermo Fisher Scientific has launched the Applied Biosystems Axiom Microbiome Array for the detection of archaea, bacteria, fungi, protozoa, and viruses in human and other samples. The array was developed in collaboration with the Lawrence Livermore National Laboratory and carries sequences from almost 13,000 species. Prior to commercialization, the array was used in a pilot study of the UK Biobank. 

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.